Heart study tests Metal-Free option for long artery blockages
NCT ID NCT06710210
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways to treat long, diffuse blockages in heart arteries. One method uses a temporary scaffold and drug-coated balloons that leave no permanent metal behind. The other uses standard metal stents. Researchers will check how well blood flow improves right after the procedure and at 12 months. The trial involves 150 adults with stable or unstable heart conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bioresorbable magnesium scaffold and drug-coated balloons
What this could lead to
If successful, this hybrid approach could offer a metal-free alternative to permanent stents for treating long coronary artery blockages, potentially reducing long-term complications.
What could go wrong
This is a small pilot study with only 150 participants, so results may not apply to everyone. The approach is new and may not be as effective or safe as standard stents.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Basel University Hospital
RECRUITINGBasel, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Geneva University Hospitals
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zurich University Hospital
RECRUITINGZurich, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••